Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
POLISH INFORMATION AND FOREIGN INVESTMENT AGENCY Economy & biotech industry in Poland Marek Łyżwa Vice-President PAIiIZ Washington DC, June 27 1 GDP growth in 2009 - 6.5% - 7.8% EU27: - 4.2% USA: - 2.4% Poland – green island on the map of Europe - 1.5% - 14.1% - 5.1% Japan: - 5.2% - 18% -4.9% - 7.1% - 14.8% - 4.9% PL + 1.7% -4% -3% - 4.9% - 4.2% - 4.7% - 3.6% - 2.6% - 1.5% - 7.8% - 5.0% - 6.3% - 7.1% - 5.8% - 5.0% - 3.6% - 2.7% - 2.0% Source: Eurostat, 2010 2 Poland seen by international companies – A.T. Kearney FDI Confidence Index 2010 • Poland – the biggest increase in comparison to the previous edition (of 2007); Country • 2nd place in Europe, 6th place in the world. 16 15 top 15 differences 11 5 4 2 2 1 0 0 0 -15 Source: AT Kearney, 2010. France Vietnam China USA Other Persian Brazil Australia Canada Germany -10 Mexico -5 Poland 0 -1 -3 -6 -9 Hong Kong 5 UK 5 UEA 10 India 20 2010 rank 2007 rank Differen ce China 1 1 0 USA 2 3 1 India 3 2 -1 Brazil 4 6 2 Germany 5 10 5 Poland 6 22 16 Australia 7 11 4 Mexico 8 19 11 Canada 9 14 5 UK 10 4 -6 UEA 11 8 -3 Vietnam 12 12 0 France 13 13 0 Hong Kong 14 5 -9 Other Persian Gulf countries 15 17 2 3 Poland’s strengths, UNCTAD Poland’s main strengths are: • Growth of the market • Size of domestic market • Access to regional markets • Cooperation with suppliers and business partners • Investment incentives system • Stable investment environment Poland is the 11th most attractive investment location in the world Source: UNCTAD, World Investment Prospects Survey 2009-2011. 4 The inflow of FDI to CEE countries in 2010 (EUR bn ) 9.9 7.5 0.6 -0.3 Lithuania 4.6 1.9 Poland 3.5 2.6 Czech. Rep. Romania 2009 2010 5 All projects served by PAIiIZ in June 2011 Countries 50 40 43 36 14 13 10 9 8 8 5 2 1 Brazil 15 20 Spain 30 Other India Japan France Germany China Korea Great Britain USA 0 Active projects served by PAIiIZ: 154 Value: EUR 5 514 mio Jobs: 36 204 Source: PAIiIZ, June, 2011. 6 Services and Manufacturing Hub in Poland (1) Automotive White goods Electronics 7 Services and Manufacturing Hub in Poland (2) Aviation BPO R&D 8 Polish biotechnology in numbers The market for biotechnology which can be used in pharmaceuticals and medicine (“red biotechnology”) is growing in Poland. Biotechnological firms are working hard on new products, the sales of which will have a substantial impact on the rate of further growth of the industry over the next years. In 2010, despite the difficult economic situation, sales of market players grew (e.g. Bioton – 75%, Mabion – more than 200%), which should lead to the improvement of the entire market (30% year-onyear increase in 2011). This is a consequence of the development of innovative projects conducted in recent years and a result of EU financial support Source: PMR 9 Polish biotechnology sector development The availability of EU funds in Poland has made it possible to support the development of biotech investments. According to the Ministry of Economy, between 2007 and 2013 companies and scientific institutions in the medical, pharmaceutical and biotechnological industries will implement projects worth around €150m (The Innovative Economy Operational Program). The fact that Polish biotech sector are just beginning to develop intensively is best illustrated by the number of new innovative ventures carried out by companies such as: Celther, Celon Pharma, Mabion, Euroimplant, Biocontract. Currently PAIiIZ is working with leading world company on the significant project of plasma fractionation in Poland. Source: PMR, PAIiIZ 10 Why Poland? Strategic location – gateway to the EU Economic and political stability Availability of skilled human resources Effective incentive system including EU-Funds 11 Thank you for your attention 00-585 Warszawa, ul. Bagatela 12 tel. (+48 22) 334 98 00, fax (+48 22) 334 99 99 e-mail: [email protected] 12